Holdings Information
Chromatin deregulation in cancer / edited by Scott A. Armstrong, Dana-Farber Cancer Institute; Steven Henikoff, Fred Hutchinson Cancer Research Center; Christopher R. Vakoc, Cold Spring Harbor Laboratory.
Bibliographic Record Display
-
Title:Chromatin deregulation in cancer / edited by Scott A. Armstrong, Dana-Farber Cancer Institute; Steven Henikoff, Fred Hutchinson Cancer Research Center; Christopher R. Vakoc, Cold Spring Harbor Laboratory.
-
Other Contributors/Collections:Armstrong, Scott A., editor.
Henikoff, Steve, editor.
Vakoc, Christopher R., editor.
-
Published/Created:Cold Spring Harbor, New York : Cold Spring Harbor Laboratory Press, 2017.
-
Holdings
Holdings Record Display
-
Location:WOODWARD LIBRARY stacksWhere is this?
-
Call Number: QZ202 .C557 2017
-
Number of Items:1
-
Status:Available
-
Location:WOODWARD LIBRARY stacksWhere is this?
-
Library of Congress Subjects:Cancer--Genetic aspects.
Chromosome abnormalities.
Mutation (Biology)
-
Medical Subjects: Neoplasms--genetics.
-
Description:vii, 382 pages : illustrations ; 27 cm
-
Series:Cold Spring Harbor perspectives in medicine.
-
Summary:"The machinery that controls how DNA is packaged and genes are activated plays an important role in cancer. This book examines the functions of components of this machinery, how they can be dysregulated, and the prospects for targeting them therapeutically. Highlights include: - PRC2 polycomb complex - Therapy- Lysine demethylase inhibitors - Epigenetic mechanisms of therapy resistance and tumor heterogeneity - Long non-coding RNA"-- Provided by publisher.
-
Notes:Includes bibliographical references and index.
-
ISBN:9781621821403 (hardback)
1621821404 (hardback)
-
Contents:Machine generated contents note: Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer / Kristian Helin
Role of Nuclear Receptor
Binding SET Domain Family Histone Lysine Methytransferases in Cancer / Jonathan D. Licht
Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia / Scott A. Armstrong
Oncogenic Mechanisms of Histone H3 Mutations / Chao Lu
MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer / Ali Shilatifard
Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer / Gerald R. Crabtree
DNMT3A in Leukemia / Margaret A. Goodell
TET2 in Normal and Malignant Hematopoiesis / Ross L. Levine
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer / Siavash K. Kurdistani
Role of Additional Sex Combs-Like Proteins in Cancer / Omar Abdel-Wahab
SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation / Ian J. Davis
ATRX and DAXX: Mechanisms and Mutations / Emily Bernstein
Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer / Alea A. Mills
Cohesin Mutations in Cancer / Ana Losada
HDACs and HDAC Inhibitors in Cancer Development and Therapy / Edward Seto
DNA Hypomethylating Drugs in Cancer Therapy / Patricia Kropf
Targeting Cancer Cells with BET Bromodomain Inhibitors / Christopher R. Vakoc
Histone Lysine Demethylase Inhibitors / Yang Shi
Mechanisms of Nucleosome Dynamics In Vivo / Steven Henikoff
Nonhistone Lysine Methylation in the Regulation of Cancer Pathways / Or Gozani
Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology / Howard Y. Chang.